Almac Group saved some stellar news for the 2014 ASCO Annual Meeting in Chicago. The U.K. life sciences contract manufacturer said it validated a new diagnostic test that spots a subset of ovarian cancer patients with greater survival odds following standard chemotherapy who should avoid a specific Roche drug.
Contract developer Almac has signed a deal to license its technology to Genomic Health for breast cancer diagnostics, reaping $9 million with the chance for a bigger payday down the road.
Almac is expanding its contract manufacturing presence in Ireland, spending about $21.5 million to bolster a production facility and add 229 jobs.
Almac is adding to a production line at a facility in Northern Ireland for its Almac Pharma Services group. The company will get some government support for the project, which will add nearly 230 jobs.
CMO Almac says its new packaging operation in Pennsylvania has garnered the FDA's approval and will soon be spitting out blister packs, bottles, wallet and vial packaging and labels.
Almac has completed its knowledge transfer partnership with Belfast's Queens University, a pairing designed to boost the CDMO's biocatalysis business.
If recent research by Novartis pans out, plants may be adding blister pack lines to help boost sales.
Add Almac to the list of CMOs banking on an explosion in the demand for commercial API production. The company has concluded an expansion of its active ingredient plant in Craigavon, U.K.
Continuing its U.S. expansion spree, pharmaceutical services company Almac is investing $10 million in a 100,000 square foot packaging plant in Audubon, PA.
Biopharma manufacturing and high-potency API production were chief drivers of facility expansions among contract manufacturers this year. Expansion activity on the whole was limited, however,